B-cell modulation of dendritic-cell function: Signals from the far side

European Journal of Immunology

Volumn 44, Issue 1, 2014, Pages 23-32

  Zietara, Natalia ^a   Lyszkiewicz, Marcin ^a   Krueger, Andreas ^a   Weiss, Siegfried ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

B cells; Cross presentation priming; Dendritic cells; Immune regulation; Immunoglobulins

Indexed keywords

CYTOKINE; FC RECEPTOR; IMMUNOGLOBULIN; INTERLEUKIN 10; INTERLEUKIN 6; LECTIN RECEPTOR; PATTERN RECOGNITION RECEPTOR;

ADAPTIVE IMMUNITY; ANTIGEN ANTIBODY COMPLEX; AUTOIMMUNITY; B LYMPHOCYTE; CELL INTERACTION; CELL POPULATION; CROSS PRESENTATION; CYTOKINE RELEASE; DENDRITIC CELL; EFFECTOR CELL; GENE EXPRESSION; GENETIC REGULATION; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNORECEPTOR TYROSINE BASED INHIBITION MOTIF; IMMUNOREGULATION; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; UPREGULATION;

ADAPTIVE IMMUNITY; ANIMALS; B-LYMPHOCYTES; CELL COMMUNICATION; CYTOKINES; DENDRITIC CELLS; HUMANS; IMMUNOGLOBULINS; IMMUNOMODULATION; RECEPTORS, FC; SIGNAL TRANSDUCTION;

EID: 84892449529     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201344007     Document Type: Short Survey

References (109)

1. Merad, M., Sathe, P., Helft, J., Miller, J. and Mortha, A., The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu. Rev. Immunol. 2013. 31: 563-604.
2. Blum, J. S., Wearsch, P. A. and Cresswell, P., Pathways of antigen processing. Annu. Rev. Immunol. 2013. 31: 443-473.
3. Hammer, G. E. and Ma, A., Molecular control of steady-state dendritic cell maturation and immune homeostasis. Annu. Rev. Immunol. 2013. 31: 743-791.
4. Segura, E. and Villadangos, J. A., A modular and combinatorial view of the antigen cross-presentation pathway in dendritic cells. Traffic 2011. 12: 1677-1685.
5. Joffre, O. P., Segura, E., Savina, A. and Amigorena, S., Cross-presentation by dendritic cells. Nat. Rev. Immunol. 2012. 12: 557-569.
6. Nierkens, S., Tel, J., Janssen, E. and Adema, G. J., Antigen cross-presentation by dendritic cell subsets: one general or all sergeants? Trends Immunol. 2013. 34: 361-370.
7. + T cells by exogenous cell-associated antigens. Immunity 2002. 17: 211-220.
8. Hildner, K., Edelson, B. T., Purtha, W. E., Diamond, M., Matsushita, H., Kohyama, M., Calderon, B. et al., Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity. Science 2008. 322: 1097-1100.
9. Heath, W. R., Belz, G. T., Behrens, G. M., Smith, C. M., Forehan, S. P., Parish, I. A., Davey, G. M. et al., Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens. Immunol. Rev. 2004. 199: 9-26.
10. + T cell tolerance. J. Exp. Med. 2002. 196: 1627-1638.
11. Shortman, K., Lahoud, M. H. and Caminschi, I., Improving vaccines by targeting antigens to dendritic cells. Exp. Mol. Med. 2009. 41: 61-66.
12. Shreedhar, V., Moodycliffe, A. M., Ullrich, S. E., Bucana, C., Kripke, M. L. and Flores-Romo, L., Dendritic cells require T cells for functional maturation in vivo. Immunity 1999. 11: 625-636.
13. Wong, B. R., Josien, R., Lee, S. Y., Sauter, B., Li, H. L., Steinman, R. M. and Choi, Y., TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J. Exp. Med. 1997. 186: 2075-2080.
14. Rizzitelli, A., Berthier, R., Collin, V., Candeias, S. M. and Marche, P. N., T lymphocytes potentiate murine dendritic cells to produce IL-12. J. Immunol. 2002. 169: 4237-4245.
15. Moulin, V., Andris, F., Thielemans, K., Maliszewski, C., Urbain, J. and Moser, M., B lymphocytes regulate dendritic cell (DC) function in vivo: increased interleukin 12 production by DCs from B cell-deficient mice results in T helper cell type 1 deviation. J. Exp. Med. 2000. 192: 475-482.
16. Lund, F. E., Cytokine-producing B lymphocytes-key regulators of immunity. Curr. Opin. Immunol. 2008. 20: 332-338.
17. Lund, F. E., Garvy, B. A., Randall, T. D. and Harris, D. P., Regulatory roles for cytokine-producing B cells in infection and autoimmune disease. Curr. Dir. Autoimmun. 2005. 8: 25-54.
18. Barr, T. A., Brown, S., Ryan, G., Zhao, J. and Gray, D., TLR-mediated stimulation of APC: distinct cytokine responses of B cells and dendritic cells. Eur. J. Immunol. 2007. 37: 3040-3053.
19. Harris, D. P., Goodrich, S., Gerth, A. J., Peng, S. L. and Lund, F. E., Regulation of IFN-gamma production by B effector 1 cells: essential roles for T-bet and the IFN-gamma receptor. J. Immunol. 2005. 174: 6781-6790.
20. Harris, D. P., Goodrich, S., Mohrs, K., Mohrs, M. and Lund, F. E., Cutting edge: the development of IL-4-producing B cells (B effector 2 cells) is controlled by IL-4, IL-4 receptor alpha, and Th2 cells. J. Immunol. 2005. 175: 7103-7107.
21. Harris, D. P., Haynes, L., Sayles, P. C., Duso, D. K., Eaton, S. M., Lepak, N. M., Johnson, L. L. et al., Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat. Immunol. 2000. 1: 475-482.
22. Yoshizaki, A., Miyagaki, T., DiLillo, D. J., Matsushita, T., Horikawa, M., Kountikov, E. I., Spolski, R. et al., Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions. Nature 2012. 491: 264-268.
23. Barr, T. A., Shen, P., Brown, S., Lampropoulou, V., Roch, T., Lawrie, S., Fan, B. et al., B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells. J. Exp. Med. 2012. 209: 1001-1010.
24. Wolf, S. D., Dittel, B. N., Hardardottir, F. and Janeway, C. A., Jr., Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J. Exp. Med. 1996. 184: 2271-2278.
25. Fillatreau, S., Sweenie, C. H., McGeachy, M. J., Gray, D. and Anderton, S. M., B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 2002. 3: 944-950.
26. Watanabe, R., Ishiura, N., Nakashima, H., Kuwano, Y., Okochi, H., Tamaki, K., Sato, S. et al., Regulatory B cells (B10 cells) have a suppressive role in murine lupus: CD19 and B10 cell deficiency exacerbates systemic autoimmunity. J. Immunol. 2010. 184: 4801-4809.
27. Haas, K. M., Watanabe, R., Matsushita, T., Nakashima, H., Ishiura, N., Okochi, H., Fujimoto, M. et al., Protective and pathogenic roles for B cells during systemic autoimmunity in NZB/W F1 mice. J. Immunol. 2010. 184: 4789-4800.
28. Jongstra-Bilen, J., Vukusic, B., Boras, K. and Wither, J. E., Resting B cells from autoimmune lupus-prone New Zealand Black and (New Zealand Black x New Zealand White)F1 mice are hyper-responsive to T cell-derived stimuli. J. Immunol. 1997. 159: 5810-5820.
29. Blair, P. A., Chavez-Rueda, K. A., Evans, J. G., Shlomchik, M. J., Eddaoudi, A., Isenberg, D. A., Ehrenstein, M. R. et al., Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-like B cells and for the suppression of lupus in MRL/lpr mice. J. Immunol. 2009. 182: 3492-3502.
30. Evans, J. G., Chavez-Rueda, K. A., Eddaoudi, A., Meyer-Bahlburg, A., Rawlings, D. J., Ehrenstein, M. R. and Mauri, C., Novel suppressive function of transitional 2 B cells in experimental arthritis. J. Immunol. 2007. 178: 7868-7878.
31. Mauri, C. and Bosma, A., Immune regulatory function of B cells. Annu. Rev. Immunol. 2012. 30: 221-241.
32. Blair, P. A., Norena, L. Y., Flores-Borja, F., Rawlings, D. J., Isenberg, D. A., Ehrenstein, M. R. and Mauri, C., CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity 2010. 32: 129-140.
33. Yanaba, K., Bouaziz, J. D., Haas, K. M., Poe, J. C., Fujimoto, M. and Tedder, T. F., A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity 2008. 28: 639-650.
34. Bouaziz, J. D., Calbo, S., Maho-Vaillant, M., Saussine, A., Bagot, M., Bensussan, A. and Musette, P., IL-10 produced by activated human B cells regulates CD4(+) T-cell activation in vitro. Eur. J. Immunol. 2010. 40: 2686-2691.
35. Maseda, D., Smith, S. H., DiLillo, D. J., Bryant, J. M., Candando, K. M., Weaver, C. T. and Tedder, T. F., Regulatory B10 cells differentiate into antibody-secreting cells after transient IL-10 production in vivo. J. Immunol. 2011. 188: 1036-1048.
36. Mizoguchi, A., Mizoguchi, E., Smith, R. N., Preffer, F. I. and Bhan, A. K., Suppressive role of B cells in chronic colitis of T cell receptor alpha mutant mice. J. Exp. Med. 1997. 186: 1749-1756.
37. Mizoguchi, A., Mizoguchi, E., Takedatsu, H., Blumberg, R. S. and Bhan, A. K., Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity 2002. 16: 219-230.
38. Mizoguchi, E., Mizoguchi, A., Preffer, F. I. and Bhan, A. K., Regulatory role of mature B cells in a murine model of inflammatory bowel disease. Int. Immunol. 2000. 12: 597-605.
39. Yanaba, K., Bouaziz, J. D., Matsushita, T., Tsubata, T. and Tedder, T. F., The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals. J. Immunol. 2009. 182: 7459-7472.
40. Matsushita, T., Yanaba, K., Bouaziz, J. D., Fujimoto, M. and Tedder, T. F., Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J. Clin. Invest. 2008. 118: 3420-3430.
41. Matsumoto, M., Fujii, Y., Baba, A., Hikida, M., Kurosaki, T. and Baba, Y., The calcium sensors STIM1 and STIM2 control B cell regulatory function through interleukin-10 production. Immunity 2011. 34: 703-714.
42. Lampropoulou, V., Hoehlig, K., Roch, T., Neves, P., Calderon Gomez, E., Sweenie, C. H., Hao, Y. et al., TLR-activated B cells suppress T cell-mediated autoimmunity. J. Immunol. 2008. 180: 4763-4773.
43. De Smedt, T., Van Mechelen, M., De Becker, G., Urbain, J., Leo, O. and Moser, M., Effect of interleukin-10 on dendritic cell maturation and function. Eur. J. Immunol. 1997. 27: 1229-1235.
44. Bhattacharyya, S., Sen, P., Wallet, M., Long, B., Baldwin, A. S., Jr. and Tisch, R., Immunoregulation of dendritic cells by IL-10 is mediated through suppression of the PI3K/Akt pathway and of IkappaB kinase activity. Blood 2004. 104: 1100-1109.
45. Takayama, T., Morelli, A. E., Onai, N., Hirao, M., Matsushima, K., Tahara, H. and Thomson, A. W., Mammalian and viral IL-10 enhance C-C chemokine receptor 5 but down-regulate C-C chemokine receptor 7 expression by myeloid dendritic cells: impact on chemotactic responses and in vivo homing ability. J. Immunol. 2001. 166: 7136-7143.
46. Steinbrink, K., Wolfl, M., Jonuleit, H., Knop, J. and Enk, A. H., Induction of tolerance by IL-10-treated dendritic cells. J. Immunol. 1997. 159: 4772-4780.
47. Buelens, C., Verhasselt, V., De Groote, D., Thielemans, K., Goldman, M. and Willems, F., Human dendritic cell responses to lipopolysaccharide and CD40 ligation are differentially regulated by interleukin-10. Eur. J. Immunol. 1997. 27: 1848-1852.
48. Skok, J., Poudrier, J. and Gray, D., Dendritic cell-derived IL-12 promotes B cell induction of Th2 differentiation: a feedback regulation of Th1 development. J. Immunol. 1999. 163: 4284-4291.
49. Mizoguchi, A. and Bhan, A. K., A case for regulatory B cells. J. Immunol. 2006. 176: 705-710.
50. Tian, J., Zekzer, D., Hanssen, L., Lu, Y., Olcott, A. and Kaufman, D. L., Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice. J. Immunol. 2001. 167: 1081-1089.
51. Douglas, R. S., Woo, E. Y., Capocasale, R. J., Tarshis, A. D., Nowell, P. C. and Moore, J. S., Altered response to and production of TGF-beta by B cells from autoimmune NZB mice. Cell. Immunol. 1997. 179: 126-137.
52. Caver, T. E., O'Sullivan, F. X., Gold, L. I. and Gresham, H. D., Intracellular demonstration of active TGFbeta1 in B cells and plasma cells of autoimmune mice. IgG-bound TGFbeta1 suppresses neutrophil function and host defense against Staphylococcus aureus infection. J. Clin. Invest. 1996. 98: 2496-2506.
53. Teranishi, T., Hirano, T., Arima, N. and Onoue, K., Human helper T cell factor(s) (ThF). II. Induction of IgG production in B lymphoblastoid cell lines and identification of T cell-replacing factor- (TRF) like factor(s). J. Immunol. 1982. 128: 1903-1908.
54. Hirano, T., Yasukawa, K., Harada, H., Taga, T., Watanabe, Y., Matsuda, T., Kashiwamura, S. et al., Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature 1986. 324: 73-76.
55. Kishimoto, T., B-cell stimulatory factors (BSFs): molecular structure, biological function, and regulation of expression. J. Clin. Immunol. 1987. 7: 343-355.
56. Muraguchi, A., Hirano, T., Tang, B., Matsuda, T., Horii, Y., Nakajima, K. and Kishimoto, T., The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells. J. Exp. Med. 1988. 167: 332-344.
57. Rieckmann, P., D'Alessandro, F., Nordan, R. P., Fauci, A. S. and Kehrl, J. H., IL-6 and tumor necrosis factor-alpha. Autocrine and paracrine cytokines involved in B cell function. J. Immunol. 1991. 146: 3462-3468.
58. Clark, E. A. and Shu, G., Association between IL-6 and CD40 signaling. IL-6 induces phosphorylation of CD40 receptors. J. Immunol. 1990. 145: 1400-1406.
59. Burdin, N., Van Kooten, C., Galibert, L., Abrams, J. S., Wijdenes, J., Banchereau, J. and Rousset, F., Endogenous IL-6 and IL-10 contribute to the differentiation of CD40-activated human B lymphocytes. J. Immunol. 1995. 154: 2533-2544.
60. Chomarat, P., Banchereau, J., Davoust, J. and Palucka, A. K., IL-6 switches the differentiation of monocytes from dendritic cells to macrophages. Nat. Immunol. 2000. 1: 510-514.
61. Park, S. J., Nakagawa, T., Kitamura, H., Atsumi, T., Kamon, H., Sawa, S., Kamimura, D. et al., IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation. J. Immunol. 2004. 173: 3844-3854.
62. Hegde, S., Pahne, J. and Smola-Hess, S., Novel immunosuppressive properties of interleukin-6 in dendritic cells: inhibition of NF-kappaB binding activity and CCR7 expression. FASEB J. 2004. 18: 1439-1441.
63. Santiago-Schwarz, F., Tucci, J. and Carsons, S. E., Endogenously produced interleukin 6 is an accessory cytokine for dendritic cell hematopoiesis. Stem Cells 1996. 14: 225-231.
64. Antonysamy, M. A., Fanslow, W. C., Fu, F., Li, W., Qian, S., Troutt, A. B. and Thomson, A. W., Evidence for a role of IL-17 in organ allograft rejection: IL-17 promotes the functional differentiation of dendritic cell progenitors. J. Immunol. 1999. 162: 577-584.
65. Bermejo, D. A., Jackson, S. W., Gorosito-Serran, M., Acosta-Rodriguez, E. V., Amezcua-Vesely, M. C., Sather, B. D., Singh, A. K. et al., Trypanosoma cruzi trans-sialidase initiates a program independent of the transcription factors RORgammat and Ahr that leads to IL-17 production by activated B cells. Nat. Immunol. 2013. 14: 514-522.
66. Nimmerjahn, F. and Ravetch, J. V., Fcgamma receptors: old friends and new family members. Immunity 2006. 24: 19-28.
67. Sancho, D. and Reis e Sousa, C., Signaling by myeloid C-type lectin receptors in immunity and homeostasis. Annu. Rev. Immunol. 2012. 30: 491-529.
68. Guermonprez, P., Valladeau, J., Zitvogel, L., Thery, C. and Amigorena, S., Antigen presentation and T cell stimulation by dendritic cells. Annu. Rev. Immunol. 2002. 20: 621-667.
69. Ouchida, R., Mori, H., Hase, K., Takatsu, H., Kurosaki, T., Tokuhisa, T., Ohno, H. et al., Critical role of the IgM Fc receptor in IgM homeostasis, B-cell survival, and humoral immune responses. Proc. Natl. Acad. Sci. USA 2012. 109: E2699-E2706.
70. Shima, H., Takatsu, H., Fukuda, S., Ohmae, M., Hase, K., Kubagawa, H., Wang, J. Y. et al., Identification of TOSO/FAIM3 as an Fc receptor for IgM. Int. Immunol. 2009. 22: 149-156.
71. Nimmerjahn, F. and Ravetch, J. V., Fcgamma receptors as regulators of immune responses. Nat. Rev. Immunol. 2008. 8: 34-47.
72. + CTL responses in vivo. J. Immunol. 2002. 168: 2240-2246.
73. Schuurhuis, D. H., van Montfoort, N., Ioan-Facsinay, A., Jiawan, R., Camps, M., Nouta, J., Melief, C. J. et al., Immune complex-loaded dendritic cells are superior to soluble immune complexes as antitumor vaccine. J. Immunol. 2006. 176: 4573-4580.
74. + T cells upon immune-complex uptake in vivo. Immunology 2006. 119: 499-506.
75. Amigorena, S., Lankar, D., Briken, V., Gapin, L., Viguier, M. and Bonnerot, C., Type II and III receptors for immunoglobulin G (IgG) control the presentation of different T cell epitopes from single IgG-complexed antigens. J. Exp. Med. 1998. 187: 505-515.
76. Simitsek, P. D., Campbell, D. G., Lanzavecchia, A., Fairweather, N. and Watts, C., Modulation of antigen processing by bound antibodies can boost or suppress class II major histocompatibility complex presentation of different T cell determinants. J. Exp. Med. 1995. 181: 1957-1963.
77. Regnault, A., Lankar, D., Lacabanne, V., Rodriguez, A., Thery, C., Rescigno, M., Saito, T. et al., Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. J. Exp. Med. 1999. 189: 371-380.
78. Kalergis, A. M. and Ravetch, J. V., Inducing tumor immunity through the selective engagement of activating Fcgamma receptors on dendritic cells. J. Exp. Med. 2002. 195: 1653-1659.
79. Rafiq, K., Bergtold, A. and Clynes, R., Immune complex-mediated antigen presentation induces tumor immunity. J. Clin. Invest. 2002. 110: 71-79.
80. van Montfoort, N., Mangsbo, S. M., Camps, M. G., van Maren, W. W., Verhaart, I. E., Waisman, A., Drijfhout, J. W. et al., Circulating specific antibodies enhance systemic cross-priming by delivery of complexed antigen to dendritic cells in vivo. Eur. J. Immunol. 2012. 42: 598-606.
81. Sedlik, C., Orbach, D., Veron, P., Schweighoffer, E., Colucci, F., Gamberale, R., Ioan-Facsinay, A. et al., A critical role for Syk protein tyrosine kinase in Fc receptor-mediated antigen presentation and induction of dendritic cell maturation. J. Immunol. 2003. 170: 846-852.
82. Woelbing, F., Kostka, S. L., Moelle, K., Belkaid, Y., Sunderkoetter, C., Verbeek, S., Waisman, A. et al., Uptake of Leishmania major by dendritic cells is mediated by Fcgamma receptors and facilitates acquisition of protective immunity. J. Exp. Med. 2006. 203: 177-188.
83. Da Silva, D. M., Fausch, S. C., Verbeek, J. S. and Kast, W. M., Uptake of human papillomavirus virus-like particles by dendritic cells is mediated by Fcgamma receptors and contributes to acquisition of T cell immunity. J. Immunol. 2007. 178: 7587-7597.
84. Li, F. and Ravetch, J. V., Inhibitory Fcgamma receptor engagement drives adjuvant and anti-tumor activities of agonistic CD40 antibodies. Science 2011. 333: 1030-1034.
85. Qiao, S. W., Kobayashi, K., Johansen, F. E., Sollid, L. M., Andersen, J. T., Milford, E., Roopenian, D. C. et al., Dependence of antibody-mediated presentation of antigen on FcRn. Proc. Natl. Acad. Sci. USA 2008. 105: 9337-9342.
86. Liu, X., Lu, L., Yang, Z., Palaniyandi, S., Zeng, R., Gao, L. Y., Mosser, D. M. et al., The neonatal FcR-mediated presentation of immune-complexed antigen is associated with endosomal and phagosomal pH and antigen stability in macrophages and dendritic cells. J. Immunol. 2011. 186: 4674-4686.
87. Dhodapkar, K. M., Krasovsky, J., Williamson, B. and Dhodapkar, M. V., Antitumor monoclonal antibodies enhance cross-presentation of cellular antigens and the generation of myeloma-specific killer T cells by dendritic cells. J. Exp. Med. 2002. 195: 125-133.
88. van Montfoort, N., Camps, M. G., Khan, S., Filippov, D. V., Weterings, J. J., Griffith, J. M., Geuze, H. J. et al., Antigen storage compartments in mature dendritic cells facilitate prolonged cytotoxic T lymphocyte cross-priming capacity. Proc. Natl. Acad. Sci. USA 2009. 106: 6730-6735.
89. Baker, K., Qiao, S. W., Kuo, T. T., Aveson, V. G., Platzer, B., Andersen, J. T., Sandlie, I. et al., Neonatal Fc receptor for IgG (FcRn) regulates cross-presentation of IgG immune complexes by CD8-CD11b+ dendritic cells. Proc. Natl. Acad. Sci. USA 2011. 108: 9927-9932.
90. Zhu, X., Meng, G., Dickinson, B. L., Li, X., Mizoguchi, E., Miao, L., Wang, Y. et al., MHC class I-related neonatal Fc receptor for IgG is functionally expressed in monocytes, intestinal macrophages, and dendritic cells. J. Immunol. 2001. 166: 3266-3276.
91. Anthony, R. M., Wermeling, F., Karlsson, M. C. and Ravetch, J. V., Identification of a receptor required for the anti-inflammatory activity of IVIG. Proc. Natl. Acad. Sci. USA 2008. 105: 19571-19578.
92. Anthony, R. M., Kobayashi, T., Wermeling, F. and Ravetch, J. V., Intravenous gammaglobulin suppresses inflammation through a novel T(H)2 pathway. Nature 2011. 475: 110-113.
93. Schwab, I. and Nimmerjahn, F., Intravenous immunoglobulin therapy: how does IgG modulate the immune system? Nat. Rev. Immunol. 2013. 13: 176-189.
94. Aghaie, A., Pourfatollah, A. A., Bathaie, S. Z., Moazzeni, S. M., Khorsand Mohammad Pour, H. and Banazadeh, S., Preparation, purification and virus inactivation of intravenous immunoglobulin from human plasma. Hum. Antibodies 2010. 19: 1-6.
95. Kasermann, F., Boerema, D. J., Ruegsegger, M., Hofmann, A., Wymann, S., Zuercher, A. W. and Miescher, S., Analysis and functional consequences of increased Fab-sialylation of intravenous immunoglobulin (IVIG) after lectin fractionation. PLoS One 2012. 7: e37243.
96. Nimmerjahn, F. and Ravetch, J. V., The antiinflammatory activity of IgG: the intravenous IgG paradox. J. Exp. Med. 2007. 204: 11-15.
97. Debre, M., Bonnet, M. C., Fridman, W. H., Carosella, E., Philippe, N., Reinert, P., Vilmer, E. et al., Infusion of Fc gamma fragments for treatment of children with acute immune thrombocytopenic purpura. Lancet 1993. 342: 945-949.
98. Kaneko, Y., Nimmerjahn, F. and Ravetch, J. V., Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science 2006. 313: 670-673.
99. Sondermann, P., Pincetic, A., Maamary, J., Lammens, K. and Ravetch, J. V., General mechanism for modulating immunoglobulin effector function. Proc. Natl. Acad. Sci. USA 2013. 110: 9868-9872.
100. Lyszkiewicz, M., Zietara, N., Rohde, M., Gekara, N. O., Jablonska, J., Dittmar, K. E. and Weiss, S., SIGN-R1+MHC II+ cells of the splenic marginal zone-a novel type of resident dendritic cells. J. Leukoc. Biol. 2011. 89: 607-615.
101. Bayry, J., Lacroix-Desmazes, S., Carbonneil, C., Misra, N., Donkova, V., Pashov, A., Chevailler, A. et al., Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin. Blood 2003. 101: 758-765.
102. Ballow, M. and Allen, C., Intravenous immunoglobulin modulates the maturation of TLR 4-primed peripheral blood monocytes. Clin. Immunol. 2011. 139: 208-214.
103. Durandy, A., Kaveri, S. V., Kuijpers, T. W., Basta, M., Miescher, S., Ravetch, J. V. and Rieben, R., Intravenous immunoglobulins-understanding properties and mechanisms. Clin. Exp. Immunol. 2009. 158(Suppl 1): 2-13.
104. Diana, J., Moura, I. C., Vaugier, C., Gestin, A., Tissandie, E., Beaudoin, L., Corthesy, B. et al., Secretory IgA induces tolerogenic dendritic cells through SIGNR1 dampening autoimmunity in mice. J. Immunol. 2013. 191: 2335-2343.
105. Monteiro, R. C. and Van De Winkel, J. G., IgA Fc receptors. Annu. Rev. Immunol. 2003. 21: 177-204.
106. Zietara, N., Lyszkiewicz, M., Puchalka, J., Pei, G., Gutierrez, M. G., Lienenklaus, S., Hobeika, E. et al., Immunoglobulins drive terminal maturation of splenic dendritic cells. Proc. Natl. Acad. Sci. USA 2013. 110: 2282-2287.
107. Mintern, J. D., Sutherland, R. M., Lew, A. M., Shortman, K., Carbone, F. R. and Heath, W. R., Constitutive, but not inflammatory, cross-presentation is disabled in the pancreas of young mice. Eur. J. Immunol. 2002. 32: 1044-1051.
108. Kollmann, T. R., Way, S. S., Harowicz, H. L., Hajjar, A. M. and Wilson, C. B., Deficient MHC class I cross-presentation of soluble antigen by murine neonatal dendritic cells. Blood 2004. 103: 4240-4242.
109. Kalpaktsoglou, P. K., Hong, R. and Good, R. A., The five classes of immunoglobulins in normal C3H and BALB/c mice. Immunology 1973. 24: 303-314.